Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

New Mountain Capital

Founders Steven Klinsky

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 29
Average round size
info
The average size of a deal this fund participated in
$102M
Portfolio companies 27
Rounds per year 1.26
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 11
Key employees 38

Areas of investment

  • Health Care
  • Information Technology
  • Consulting
  • Medical
  • Software
Summary

New Mountain Capital appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the New Mountain Capital, startups are often financed by Venrock, Summit Partners, Noro-Moseley Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, ARCH Venture Partners, Vestar Capital Partners. In the next rounds fund is usually obtained by Vestar Capital Partners, Frazier Healthcare Partners.

Comparing to the other companies, this New Mountain Capital performs on 2 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2015. The usual things for fund are deals in the range of more than 100 millions dollars. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity.

Among the most popular portfolio startups of the fund, we may highlight Ikaria, IRI, Stroz Friedberg. Among the most successful fund investment fields, there are Biotechnology, Medical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The current fund was established by Steven Klinsky. Besides them, we counted 39 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of New Mountain Capital:
Typical Co-investors
New Mountain Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after New Mountain Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1823 Ventures Central, Central Region, Singapore
AMS INDUSTRIES France, Ile-de-France, Paris
Archer Investment Management North Carolina, Raleigh, United States
Central Illinois Angels Illinois, Peoria, United States
Centre for Drug Design & Discovery (CD3) Belgium, Flemish Brabant, Vlaams-Brabant
Ipanema Technologies Courceboeufs, France, Pays de la Loire
Kepventure Pte Ltd -
Less Plastics Canada, Gatineau, Quebec
Long Venture Partners California, San Francisco, United States
prominent venture capital -
Qingyuan Xinlin Venture Investment Management China, Jiangsu, Suzhou
RPS Ventures California, Palo Alto, United States
Seneca Partners Birmingham, Michigan, United States
Shubei Investment China, Hangzhou, Zhejiang
Summit Capital Seattle, United States, Washington
The Future Fund England, London, United Kingdom
Victorian Clean Technology Fund -
Wittington Portland Murdoch -
Zhehua Investment China, Jiaxing, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Bellerophon Therapeutics

Biotechnology
Health Care
Medical
$80M26 Dec 2013 New Jersey, United States

Ikaria

Biotechnology
Medical
Therapeutics
$280M01 Mar 2007 Hampton, New Jersey, United States
News
Bounteous Receives Strategic Investment From New Mountain Capital

– Bounteous, a Chicago, IL-based insights-driven digital experience consultancy, received an investment from New Mountain Capital.
– The amount of the deal was not disclosed.
– The company intends to use the funds to make strategic investments in talent, new service offerings, and the Co-Innovation enablement methods that it uses to drive clients’ digital transformation programs.

HomeX Closes $90M in Funding

– HomeX from Chicago provides a home services platform for homeowners and service providers.
– The company closed $90m in funding.
– The round was led by New Mountain Capital.
– The company intends to use the funds to expand its services across North America.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent New Mountain Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 29
Average round size 102M
Rounds per year 1.26
Peak activity year 2017
Lead investments 10
Follow on index 0.07
Exits 11
Group Appearance index 0.21

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Bellerophon Therapeutics

Biotechnology
Health Care
Medical
$80M26 Dec 2013 New Jersey, United States

Ikaria

Biotechnology
Medical
Therapeutics
$280M01 Mar 2007 Hampton, New Jersey, United States
Crunchbase icon

Content report

The following text will be sent to our editors: